Neutrophils mediate blood-spinal cord barrier disruption in demyelinating neuroinflammatory diseases

Journal of Immunology

Volumn 193, Issue 5, 2014, Pages 2438-2454

  Aubé, Benoit ^a,b,c   Lévesque, Sébastien A ^a,b   Paré, Alexandre ^a,b   Chamma, Émilie ^a,c   Kébir, Hania ^d   Gorina, Roser ^e   Lécuyer, Marc André ^d   Alvarez, Jorge I ^d   De Koninck, Yves ^a   Engelhardt, Britta ^e   Prat, Alexandre ^d   Côté, Daniel ^a,c   Lacroix, Steve ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

^d UNIVERSITY OF MONTREAL   (Canada)

^e UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; INTERLEUKIN 1 RECEPTOR TYPE I;

ACUTE DISEASE; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BLOOD CELL; BLOOD SPINAL CORD BARRIER DISRUPTION; BLOOD SPINAL CORD BARRIER PERMEABILITY; BONE MARROW CELL; CELL ADHESION; CELL KINETICS; CONTROLLED STUDY; DEMYELINATING DISEASE; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKOCYTE FUNCTION; LEUKOPENIA; MALE; MOUSE; MULTIPLE SCLEROSIS; MYELITIS; MYELOOPTIC NEUROPATHY; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PATHOPHYSIOLOGY; PERMEABILITY BARRIER; PROTEIN FUNCTION; SPINAL CORD DISEASE; VASCULITIS; VIDEO MICROSCOPY; ANIMAL; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; GENETICS; IMMUNOLOGY; NEUTROPHIL; PATHOLOGY; SPINAL CORD; TRANSGENIC MOUSE;

ANIMALS; BLOOD-BRAIN BARRIER; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; HUMANS; MICE; MICE, TRANSGENIC; NEUROMYELITIS OPTICA; NEUTROPHILS; SPINAL CORD;

EID: 84906841402     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400401     Document Type: Article

References (93)

1. Hickey, W. F. 2001. Basic principles of immunological surveillance of the normal central nervous system. Glia 36: 118-124.
2. Ransohoff, R. M., and B. Engelhardt. 2012. The anatomical and cellular basis of immune surveillance in the central nervous system. Nat. Rev. Immunol. 12: 623-635.
3. Zlokovic, B. V. 2008. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57: 178-201.
4. Bennett, J., J. Basivireddy, A. Kollar, K. E. Biron, P. Reickmann, W. A. Jefferies, and S. McQuaid. 2010. Blood-brain barrier disruption and enhanced vascular permeability in the multiple sclerosis model EAE. J. Neuroimmunol. 229: 180-191.
5. Popescu, B. F., and C. F. Lucchinetti. 2012. Pathology of demyelinating diseases. Annu. Rev. Pathol. 7: 185-217.
6. Stamatovic S. M., P. Shakui, R. F. Keep, B. B. Moore, S. L. Kunkel, N. Van Rooijen, and A. V. Andjelkovic. 2005. Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability. J. Cereb. Blood Flow Metab. 25: 593-606.
7. Zhu, W., N. R. London, C. C. Gibson, C. T. Davis, Z. Tong, L. K. Sorensen, D. S. Shi, J. Guo, M. C. Smith, A. H. Grossmann, et al. 2012. Interleukin receptor activates a MYD88-ARNO-ARF6 cascade to disrupt vascular stability. Nature 492: 252-255.
8. Cristante, E., S. McArthur, C. Mauro, E. Maggioli, I. A. Romero, M. Wylezinska-Arridge, P. O. Couraud, J. Lopez-Tremoleda, H. C. Christian, B. B. Weksler, et al. 2013. Identification of an essential endogenous regulator of blood-brain barrier integrity, and its pathological and therapeutic implications. Proc. Natl. Acad. Sci. USA 110: 832-841.
9. Tonra, J. R., B. S. Reiseter, R. Kolbeck, K. Nagashima, R. Robertson, B. Keyt, and R. M. Lindsay. 2001. Comparison of the timing of acute blood-brain barrier breakdown to rabbit immunoglobulin G in the cerebellum and spinal cord of mice with experimental autoimmune encephalomyelitis. J. Comp. Neurol. 430: 131-144.
10. Floris, S., E. L. Blezer, G. Schreibelt, E. Dopp, S. M. van der Pol, I. L. Schadee-Eestermans, K. Nicolay, C. D. Dijkstra, and H. E. de Vries. 2004. Blood-brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis: a quantitative MRI study. Brain 127: 616-627.
11. Muller, D. M., M. P. Pender, and J. M. Greer. 2005. Blood-brain barrier disruption and lesion localisation in experimental autoimmune encephalomyelitis with predominant cerebellar and brainstem involvement. J. Neuroimmunol. 160: 162-169.
12. Schellenberg, A. E., R. Buist, V. W. Yong, M. R. Del Bigio, and J. Peeling. 2007. Magnetic resonance imaging of blood-spinal cord barrier disruption in mice with experimental autoimmune encephalomyelitis. Magn. Reson. Med. 58: 298-305.
13. Christy, A. L., M. E. Walker, M. J. Hessner, and M. A. Brown. 2013. Mast cell activation and neutrophil recruitment promotes early and robust inflammation in the meninges in EAE. J. Autoimmun. 42: 50-61.
14. De Filippo, K., A. Dudeck, M. Hasenberg, E. Nye, N. van Rooijen, K. Hartmann, M. Gunzer, A. Roers, and N. Hogg. 2013. Mast cell and macrophage chemokines CXCL1/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation. Blood 121: 4930-4937.
15. Kroenke, M. A., T. J. Carlson, A. V. Andjelkovic, and B. M. Segal. 2008. IL-12-and IL-23-modulated T cells induce distinct types of EAE based on histology, CNS chemokine profile, and response to cytokine inhibition. J. Exp. Med. 205: 1535-1541.
16. Carlson, T., M. Kroenke, P. Rao, T. E. Lane, and B. Segal. 2008. The Th17-ELR+ CXC chemokine pathway is essential for the development of central nervous system autoimmune disease. J. Exp. Med. 205: 811-823.
17. Tran, E. H., E. N. Prince, and T. Owens. 2000. IFN-γ shapes immune invasion of the central nervous system via regulation of chemokines. J. Immunol. 164: 2759-2768.
18. Wu, F., W. Cao, Y. Yang, and A. Liu. 2010. Extensive infiltration of neutrophils in the acute phase of experimental autoimmune encephalomyelitis in C57BL/6 mice. Histochem. Cell Biol. 133: 313-322.
19. Mantovani, A., M. A. Cassatella, C. Costantini, and S. Jaillon. 2011. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat. Rev. Immunol. 11: 519-531.
20. Beyrau, M., J. V. Bodkin, and S. Nourshargh. 2012. Neutrophil heterogeneity in health and disease: a revitalized avenue in inflammation and immunity. Open Biol. 2: 120134.
21. Jaillon, S., M. R. Galdiero, D. Del Prete, M. A. Cassatella, C. Garlanda, and A. Mantovani. 2013. Neutrophils in innate and adaptive immunity. Semin. Immunopathol. 35: 377-394.
22. Bennouna, S., S. K. Bliss, T. J. Curiel, and E. Y. Denkers. 2003. Cross-talk in the innate immune system: neutrophils instruct recruitment and activation of dendritic cells during microbial infection. J. Immunol. 171: 6052-6058.
23. van Gisbergen, K. P., M. Sanchez-Hernandez, T. B. Geijtenbeek, and Y. van Kooyk. 2005. Neutrophils mediate immune modulation of dendritic cells through glycosylation-dependent interactions between Mac-1 and DC-SIGN. J. Exp. Med. 201: 1281-1292.
24. Goverman, J. 2009. Autoimmune T cell responses in the central nervous system. Nat. Rev. Immunol. 9: 393-407.
25. Pierson, E., S. B. Simmons, L. Castelli, and J. M. Goverman. 2012. Mechanisms regulating regional localization of inflammation during CNS autoimmunity. Immunol. Rev. 248: 205-215.
26. Ransohoff, R. M., and M. A. Brown. 2012. Innate immunity in the central nervous system. J. Clin. Invest. 122: 1164-1171.
27. Steinbach, K., M. Piedavent, S. Bauer, J. T. Neumann, and M. A. Friese. 2013. Neutrophils amplify autoimmune central nervous system infiltrates by maturing local APCs. J. Immunol. 191: 4531-4539.
28. Zhou, J., S. A. Stohlman, D. R. Hinton, and N. W. Marten. 2003. Neutrophils promote mononuclear cell infiltration during viral-induced encephalitis. J. Immunol. 170: 3331-3336.
29. Odobasic, D., A. R. Kitching, Y. Yang, K. M. O'Sullivan, R. C. Muljadi, K. L. Edgtton, D. S. Tan, S. A. Summers, E. F. Morand, and S. R. Holdsworth. 2013. Neutrophil myeloperoxidase regulates T-cell-driven tissue inflammation in mice by inhibiting dendritic cell function. Blood 121: 4195-4204.
30. Scapini, P., J. A. Lapinet-Vera, S. Gasperini, F. Calzetti, F. Bazzoni, and M. A. Cassatella. 2000. The neutrophil as a cellular source of chemokines. Immunol. Rev. 177: 195-203.
31. Abi Abdallah, D. S., C. E. Egan, B. A. Butcher, and E. Y. Denkers. 2011. Mouse neutrophils are professional antigen-presenting cells programmed to instruct Th1 and Th17 T-cell differentiation. Int. Immunol. 23: 317-326.
32. McColl, S. R., M. A. Staykova, A. Wozniak, S. Fordham, J. Bruce, and D. O. Willenborg. 1998. Treatment with anti-granulocyte antibodies inhibits the effector phase of experimental autoimmune encephalomyelitis. J. Immunol. 161: 6421-6426.
33. Misgeld, T., and M. Kerschensteiner. 2006. In vivo imaging of the diseased nervous system. Nat. Rev. Neurosci. 7: 449-463.
34. Davalos, D., J. K. Ryu, M. Merlini, K. M. Baeten, N. Le Moan, M. A. Petersen, T. J. Deerinck, D. S. Smirnoff, C. Bedard, H. Hakozaki, et al. 2012. Fibrinogeninduced perivascular microglial clustering is required for the development of axonal damage in neuroinflammation. Nat. Commun. 3: 1227.
35. Niesner, R., V. Siffrin, and F. Zipp. 2013. Two-photon imaging of immune cells in neural tissue. Cold Spring Harbor Protoc. 2013: pdb.prot073528.
36. Stromnes, I. M., and J. M. Goverman. 2006. Active induction of experimental allergic encephalomyelitis. Nat. Protoc. 1: 1810-1819.
37. Soulet, D., A. Paré, J. Coste, and S. Lacroix. 2013. Automated filtering of intrinsic movement artifacts during two-photon intravital microscopy. PLoS ONE 8: e53942.
38. de Rivero Vaccari, J. P., D. Bastien, G. Yurcisin, I. Pineau, W. D. Dietrich, Y. De Koninck, R. W. Keane, and S. Lacroix. 2012. P2X4 receptors influence inflammasome activation after spinal cord injury. J. Neurosci. 32: 3058-3066.
39. Sedgwick, J. D., S. Schwender, H. Imrich, R. Dörries, G. W. Butcher, and V. ter Meulen. 1991. Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. Proc. Natl. Acad. Sci. USA 88: 7438-7442.
40. Babcock, A. A., W. A. Kuziel, S. Rivest, and T. Owens. 2003. Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS. J. Neurosci. 23: 7922-7930.
41. Barrette, B., M. A. Hébert, M. Filali, K. Lafortune, N. Vallières, G. Gowing, J. P. Julien, and S. Lacroix. 2008. Requirement of myeloid cells for axon regeneration. J. Neurosci. 28: 9363-9376.
42. Pineau, I., L. Sun, D. Bastien, and S. Lacroix. 2010. Astrocytes initiate inflammation in the injured mouse spinal cord by promoting the entry of neutrophils and inflammatory monocytes in an IL-1 receptor/MyD88-dependent fashion. Brain Behav. Immun. 24: 540-553.
43. Nadeau, S., M. Filali, J. Zhang, B. J. Kerr, S. Rivest, D. Soulet, Y. Iwakura, J. P. de Rivero Vaccari, R. W. Keane, and S. Lacroix. 2011. Functional recovery after peripheral nerve injury is dependent on the pro-inflammatory cytokines IL-1β and TNF: implications for neuropathic pain. J. Neurosci. 31: 12533-12542.
44. Ribes, S., T. Regen, T. Meister, S. C. Tauber, S. Schütze, A. Mildner, M. Mack, U. K. Hanisch, and R. Nau. 2013. Resistance of the brain to Escherichia coli K1 infection depends on MyD88 signaling and the contribution of neutrophils and monocytes. Infect. Immun. 81: 1810-1819.
45. Tung, J. W., K. Heydari, R. Tirouvanziam, B. Sahaf, D. R. Parks, L. A. Herzenberg, and L. A. Herzenberg. 2007. Modern flow cytometry: a practical approach. Clin. Lab. Med. 27: 453-468, v (v.).
46. Jutila, M. A., F. G. Kroese, K. L. Jutila, A. M. Stall, S. Fiering, L. A. Herzenberg, E. L. Berg, and E. C. Butcher. 1988. Ly-6C is a monocyte/macrophage and endothelial cell differentiation antigen regulated by interferon-gamma. Eur. J. Immunol. 18: 1819-1826.
47. Hestdal, K., F. W. Ruscetti, J. N. Ihle, S. E. Jacobsen, C. M. Dubois, W. C. Kopp, D. L. Longo, and J. R. Keller. 1991. Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells. J. Immunol. 147: 22-28.
48. Daley, J. M., A. A. Thomay, M. D. Connolly, J. S. Reichner, and J. E. Albina. 2008. Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J. Leukoc. Biol. 83: 64-70.
49. Tate, M. D., Y. M. Deng, J. E. Jones, G. P. Anderson, A. G. Brooks, and P. C. Reading. 2009. Neutrophils ameliorate lung injury and the development of severe disease during influenza infection. J. Immunol. 183: 7441-7450.
50. Coisne, C., and B. Engelhardt. 2010. Preclinical testing of strategies for therapeutic targeting of human T-cell trafficking in vivo. Methods Mol. Biol. 616: 268-281.
51. Vajkoczy, P., M. Laschinger, and B. Engelhardt. 2001. α4-integrin-VCAM-1 binding mediates G protein-independent capture of encephalitogenic T cell blasts to CNS white matter microvessels. J. Clin. Invest. 108: 557-565.
52. Farrar, M. J., I. M. Bernstein, D. H. Schlafer, T. A. Cleland, J. R. Fetcho, and C. B. Schaffer. 2012. Chronic in vivo imaging in the mouse spinal cord using an implanted chamber. Nat. Methods 9: 297-302.
53. Fenrich, K. K., P. Weber, M. Hocine, M. Zalc, G. Rougon, and F. Debarbieux. 2012. Long-term in vivo imaging of normal and pathological mouse spinal cord with subcellular resolution using implanted glass windows. J. Physiol. 590: 3665-3675.
54. Fleming, K. K., J. A. Bovaird, M. C. Mosier, M. R. Emerson, S. M. LeVine, and J. G. Marquis. 2005. Statistical analysis of data from studies on experimental autoimmune encephalomyelitis. J. Neuroimmunol. 170: 71-84.
55. Fabis, M. J., G. S. Scott, R. B. Kean, H. Koprowski, and D. C. Hooper. 2007. Loss of blood-brain barrier integrity in the spinal cord is common to experimental allergic encephalomyelitis in knockout mouse models. Proc. Natl. Acad. Sci. USA 104: 5656-5661.
56. Linthicum, D. S., J. J. Munoz, and A. Blaskett. 1982. Acute experimental autoimmune encephalomyelitis in mice. I. Adjuvant action of Bordetella pertussis is due to vasoactive amine sensitization and increased vascular permeability of the central nervous system. Cell. Immunol. 73: 299-310.
57. Sudweeks, J. D., J. A. Todd, E. P. Blankenhorn, B. B. Wardell, S. R. Woodward, N. D. Meeker, S. S. Estes, and C. Teuscher. 1993. Locus controlling Bordetella pertussis-induced histamine sensitization (Bphs), an autoimmune diseasesusceptibility gene, maps distal to T-cell receptor βb-chain gene on mouse chromosome 6. Proc. Natl. Acad. Sci. USA 90: 3700-3704.
58. Yong, T., G. A. Meininger, and D. S. Linthicum. 1993. Enhancement of histamine-induced vascular leakage by pertussis toxin in SJL/J mice but not BALB/c mice. J. Neuroimmunol. 45: 47-52.
59. Richard, J. F., M. Roy, J. Audoy-Rémus, P. Tremblay, and L. Vallières. 2011. Crawling phagocytes recruited in the brain vasculature after pertussis toxin exposure through IL6, ICAM1 and ITGaM. Brain Pathol. 21: 661-671.
60. Faust, N., F. Varas, L. M. Kelly, S. Heck, and T. Graf. 2000. Insertion of enhanced green fluorescent protein into the lysozyme gene creates mice with green fluorescent granulocytes and macrophages. Blood 96: 719-726.
61. Mawhinney, L. A., S. G. Thawer, W. Y. Lu, Nv. Rooijen, L. C. Weaver, A. Brown, and G. A. Dekaban. 2012. Differential detection and distribution of microglial and hematogenous macrophage populations in the injured spinal cord of lys-EGFP-ki transgenic mice. J. Neuropathol. Exp. Neurol. 71: 180-197.
62. Soulika, A. M., E. Lee, E. McCauley, L. Miers, P. Bannerman, and D. Pleasure. 2009. Initiation and progression of axonopathy in experimental autoimmune encephalomyelitis. J. Neurosci. 29: 14965-14979.
63. Larochelle, C., J. I. Alvarez, and A. Prat. 2011. How do immune cells overcome the blood-brain barrier in multiple sclerosis? FEBS Lett. 585: 3770-3780.
64. Chen, C. J., H. Kono, D. Golenbock, G. Reed, S. Akira, and K. L. Rock. 2007. Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat. Med. 13: 851-856.
65. Chen, C. J., Y. Shi, A. Hearn, K. Fitzgerald, D. Golenbock, G. Reed, S. Akira, and K. L. Rock. 2006. MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals. J. Clin. Invest. 116: 2262-2271.
66. Schiffenbauer, J., W. J. Streit, E. Butfiloski, M. LaBow, C. Edwards, III, and L. L. Moldawer. 2000. The induction of EAE is only partially dependent on TNF receptor signaling but requires the IL-1 type I receptor. Clin. Immunol. 95: 117-123.
67. Sutton, C., C. Brereton, B. Keogh, K. H. Mills, and E. C. Lavelle. 2006. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 203: 1685-1691.
68. Li, Q., N. Powell, H. Zhang, N. Belevych, S. Ching, Q. Chen, J. Sheridan, C. Whitacre, and N. Quan. 2011. Endothelial IL-1R1 is a critical mediator of EAE pathogenesis. Brain Behav. Immun. 25: 160-167.
69. Kitic, M., S. Hochmeister, I. Wimmer, J. Bauer, T. Misu, S. Mader, M. Reindl, K. Fujihara, H. Lassmann, and M. Bradl. 2013. Intrastriatal injection of interleukin-1β triggers the formation of neuromyelitis optica-like lesions in NMOIgG seropositive rats. Acta Neuropathol. Commun. 1: 5.
70. Enzmann, G., C. Mysiorek, R. Gorina, Y. J. Cheng, S. Ghavampour, M. J. Hannocks, V. Prinz, U. Dirnagl, M. Endres, M. Prinz, et al. 2013. The neurovascular unit as a selective barrier to polymorphonuclear granulocyte (PMN) infiltration into the brain after ischemic injury. Acta Neuropathol. 125: 395-412.
71. Daniel, P. M., D. K. Lam, and O. E. Pratt. 1981. Changes in the effectiveness of the blood-brain and blood-spinal cord barriers in experimental allergic encephalomyelitis. J. Neurol. Sci. 52: 211-219.
72. Juhler, M., D. I. Barry, H. Offner, G. Konat, L. Klinken, and O. B. Paulson. 1984. Blood-brain and blood-spinal cord barrier permeability during the course of experimental allergic encephalomyelitis in the rat. Brain Res. 302: 347-355.
73. Fabis, M. J., T. W. Phares, R. B. Kean, H. Koprowski, and D. C. Hooper. 2008. Blood-brain barrier changes and cell invasion differ between therapeutic immune clearance of neurotrophic virus and CNS autoimmunity. Proc. Natl. Acad. Sci. USA 105: 15511-15516.
74. Sayed, B. A., A. L. Christy, M. E. Walker, and M. A. Brown. 2010. Meningeal mast cells affect early T cell central nervous system infiltration and blood-brain barrier integrity through TNF: a role for neutrophil recruitment? J. Immunol. 184: 6891-6900.
75. Kermode, A. G., A. J. Thompson, P. Tofts, D. G. MacManus, B. E. Kendall, D. P. Kingsley, I. F. Moseley, P. Rudge, and W. I. McDonald. 1990. Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. Brain 113: 1477-1489.
76. Stone, L. A., M. E. Smith, P. S. Albert, C. N. Bash, H. Maloni, J. A. Frank, and H. F. McFarland. 1995. Blood-brain barrier disruption on contrast-enhanced MRI in patients with mild relapsing-remitting multiple sclerosis: relationship to course, gender, and age. Neurology 45: 1122-1126.
77. Kang, E. J., S. Major, D. Jorks, C. Reiffurth, N. Offenhauser, A. Friedman, and J. P. Dreier. 2013. Blood-brain barrier opening to large molecules does not imply blood-brain barrier opening to small ions. Neurobiol. Dis. 52: 204-218.
78. Owens, T., I. Bechmann, and B. Engelhardt. 2008. Perivascular spaces and the two steps to neuroinflammation. J. Neuropathol. Exp. Neurol. 67: 1113-1121.
79. Armulik, A., G. Genové, M. Mäe, M. H. Nisancioglu, E. Wallgard, C. Niaudet, L. He, J. Norlin, P. Lindblom, K. Strittmatter, et al. 2010. Pericytes regulate the blood-brain barrier. Nature 468: 557-561.
80. Stanimirovic, D. B., and A. Friedman. 2012. Pathophysiology of the neurovascular unit: disease cause or consequence? J. Cereb. Blood Flow Metab. 32: 1207-1221.
81. Anthony, D. C., S. J. Bolton, S. Fearn, and V. H. Perry. 1997. Age-related effects of interleukin-1 beta on polymorphonuclear neutrophil-dependent increases in blood-brain barrier permeability in rats. Brain 120: 435-444.
82. Argaw, A. T., Y. Zhang, B. J. Snyder, M. L. Zhao, N. Kopp, S. C. Lee, C. S. Raine, C. F. Brosnan, and G. R. John. 2006. IL-1β regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program. J. Immunol. 177: 5574-5584.
83. Reboldi, A., C. Coisne, D. Baumjohann, F. Benvenuto, D. Bottinelli, S. Lira, A. Uccelli, A. Lanzavecchia, B. Engelhardt, and F. Sallusto. 2009. C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat. Immunol. 10: 514-523.
84. Pelletier, M., L. Maggi, A. Micheletti, E. Lazzeri, N. Tamassia, C. Costantini, L. Cosmi, C. Lunardi, F. Annunziato, S. Romagnani, and M. A. Cassatella. 2010. Evidence for a cross-talk between human neutrophils and Th17 cells. Blood 115: 335-343.
85. Nygårdas, P. T., J. A. Määttä, and A. E. Hinkkanen. 2000. Chemokine expression by central nervous system resident cells and infiltrating neutrophils during experimental autoimmune encephalomyelitis in the BALB/c mouse. Eur. J. Immunol. 30: 1911-1918.
86. Zehntner, S. P., C. Brickman, L. Bourbonniere, L. Remington, M. Caruso, and T. Owens. 2005. Neutrophils that infiltrate the central nervous system regulate T cell responses. J. Immunol. 174: 5124-5131.
87. DiStasi, M. R., and K. Ley. 2009. Opening the flood-gates: how neutrophilendothelial interactions regulate permeability. Trends Immunol. 30: 547-556.
88. Engelhardt, B., and R. M. Ransohoff. 2012. Capture, crawl, cross: the T cell code to breach the blood-brain barriers. Trends Immunol. 33: 579-589.
89. Allen, C., P. Thornton, A. Denes, B. W. McColl, A. Pierozynski, M. Monestier, E. Pinteaux, N. J. Rothwell, and S. M. Allan. 2012. Neutrophil cerebrovascular transmigration triggers rapid neurotoxicity through release of proteases associated with decondensed DNA. J. Immunol. 189: 381-392.
90. Stockinger, B., and M. Veldhoen. 2007. Differentiation and function of Th17 T cells. Curr. Opin. Immunol. 19: 281-286.
91. Codarri, L., G. Gyülvészi, V. Tosevski, L. Hesske, A. Fontana, L. Magnenat, T. Suter, and B. Becher. 2011. RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 12: 560-567.
92. El-Behi, M., B. Ciric, H. Dai, Y. Yan, M. Cullimore, F. Safavi, G. X. Zhang, B. N. Dittel, and A. Rostami. 2011. The encephalitogenicity of TH17 cells is dependent on IL-1-and IL-23-induced production of the cytokine GM-CSF. Nat. Immunol. 12: 568-575.
93. Hoffmann, A., J. Bredno, M. Wendland, N. Derugin, P. Ohara, and M.Wintermark. 2011. High and low molecular weight fluorescein isothiocyanate (FITC)-dextrans to assess blood-brain barrier disruption: technical considerations. Transl. Stroke Res. 2: 106-111.